FDA.reportPublic FDA data

Tazorac 0.5 MG in 1 GM Topical Gel

RxCUI
212437
RxNorm name
Tazorac 0.5 MG in 1 GM Topical Gel
Display name
Tazorac 0.5 MG in 1 GM Topical Gel
Full name
Tazorac 0.5 MG in 1 GM Topical Gel
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:38:57

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
TazoracTAZAROTENEAlmirall, LLC4e4e4b81-420e-4492-8a74-80b692a800572025-11-13Warnings, Adverse reactionsExact identifier
rxcui: 212437

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
4e4e4b81-420e-4492-8a74-80b692a80057TAZORAC 0.05 % Topical Gel [PSN] · tazarotene 0.0005 MG/MG Topical Gel [Tazorac] [SBD] · Tazorac 0.0005 MG/MG Topical Gel [SY] · Tazorac 0.05 % Topical Gel [SY] · Tazorac 0.5 MG in 1 GM Topical Gel [SY]54These highlights do not include all the information needed to use TAZORAC ® Gel safely and effectively. See full prescribing information for TAZORAC ® Gel. TAZORAC ® (tazarotene) gel, 0.05% and 0.1%, for topical use Initial U.S. Approval: 199720251113